EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) announced the appointment of Nils Bergenhem, Ph.D., as its new Chief Scientific Officer, effective February 1, 2010. Dr. Bergenhem will succeed Fred Feldman, Ph.D., who is retiring after a 35 year career in research and drug development. Dr. Feldman has served as the Chief Science Officer of CPEX since its spin-off from Bentley Pharmaceuticals, Inc. in 2008. Dr. Feldman will work with Dr. Bergenhem and CPEX for an interim period to ensure a smooth transition.
